knowing and comparing the Efficacy and safety of Minoxidil versus Botulinum Toxin A in the treatment of male pattern baldness in a tertiary care centre.
Not Applicable
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2021/10/037686
- Lead Sponsor
- vilashini
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
clinically diagnosed Norwood Hamilton grade 2 to 4 of androgenetic alopecia
Exclusion Criteria
patients with other grades of androgenetic alopecia
patients with concomitant diagnosis of alopecia aereata
localised infection of scalp
patients on anti coagulants
patients with needle phobia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method